Patient Support Services Contact Us
Image: Coherus Investors

Snapshot

Revenue & Earnings

Revenue (FY) $475.82
EBIT (Mil) (FY) $156.32
EBIT (Mil) (MRQ) $-24.16
EBIT (Mil) (TTM) $-141.38
EBITDA (Mil) (FY) $159.22
EBITDA (Mil) (MRQ) $-23.29
EBITDA (Mil) (TTM) $-138.06
Net Income Excluding Extraordinary Items (Mil) (FY) $132.24
Net Income Including Extraordinary Items (Mil) (FY) $132.24
Diluted EPS Excluding Extraordinary Items (FY) $1.62
Diluted EPS Including Extraordinary Items (FY) $1.62

Dividends

Yield (%) --
Dividend Record Date
Dividend Rate --%

Ratios

Price to Revenue (TTM) $3.25
Price to Revenue (MRQ) $3.65
Price to Revenue (FY) $2.70
Price To Cash Flow (TTM) --
Price to Cash Flow (MRQ) --
Price to Cash Flow (FY) $9.50
Price to Book (MRQ) $8.22
Price to Book (FY) $4.33
Total Debt to Equity (MRQ) (%) 259.94%
Total Debt to Equity (FY) (%) 144.30%
Current Ratio (MRQ) $2.30
Current Ratio (FY) $5.27

Growth

5-Year Annual Dividend Growth Rate (%) --%
5-Year Annual Revenue Growth Rate (%) 73.76%

FY = Fiscal Year. MRQ = Most Recent Quarter. mil = Millions. TTM = Trailing Twelve Months.

Copyright Refinitiv